Local Institution - 0168

Beijing, Beijing Municipality 100142

1 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Metastatic Castration-resistant Prostate Cancer

Studies at this site

• A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer — Recruiting now
• A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3) — Running, not enrolling